Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients

Mi.M., Ma.M., K.H., C-H.T., B.J., N.N., T.O., M.Y., W.Z.R., D.R., S.E., K.C., and J.B. were the guarantors; Mi.M., Ma.M., K.H., C-H.T., B.J., N.N., T.O., K.C., and J.B. were involved in the conception, organization, and/or execution of the research project; M.Y. and W.Z.R. were involved in the statistical analysis; Mi.M., Ma.M., K.H., C-H.T., B.J., N.N., T.O., M.Y., W.Z.R., D.R., S.E., K.C., J.B. were involved with the review and critique of the analysis; Mi.M., Ma.M., K.H., C-H.T., B.J., N.N., T.O., M.Y., W.Z.R., D.R., S.E., K.C., J.B. were involved in the writing and reviewing of the manuscript